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 Ethyl N-lauroyl L-arginate hydrochloride (LAE) was coupled with hyaluronic acid (HyA) 2 
to form ionic complexes with LAE to HyA ratios of 1:1 and 1:2. The complexes were extensively 3 
characterized by FTIR and NMR spectroscopies and their thermal properties evaluated by 4 
thermogravimetry and calorimetry. Thin films prepared from these complexes by casting 5 
displayed a smectic-like structure based on an ordered arrangement of LAE and HyA layers 6 
with a nanometric periodicity of 3.8-3.9 nm. Films immersed in water at pH 7.4 and 5.5 7 
dissociated to deliver free LAE to the environment and reaching the equilibrium in few hours. 8 
The biocide activity of these films against both Gram-positive and Gram-negative bacteria was 9 
preliminary assessed by the liquid medium method, and shown to be notable in both cases. The 10 
antibacterial property of the complexes was found to increase with the content of LAE and to be 11 








1. Introduction 13 
 Complexation of polyelectrolytes with counter-ions of low molecular weight is a relatively 14 
simple approach recurrently used for creating materials that largely differ in properties from the 15 
parent polymer. This is so because coupling between complementary ionic building-blocks 16 
usually leads to molecular arrangements able to self-assemble in well-organized nanostructures 17 
(Macknight, Ponomarenko, & Tirrell, 1998a). The complexes made of ionic polypeptides and 18 
tetraalkylsurfactants constitute a representative example of these systems (Hanski et al., 2006; 19 
Macknight, Ponomarenko, & Tirrel, 1998b; Pérez-Camero et al., 2004; Ponomarenko, Waddon, 20 
Tirrell, & MacKnight, 1996). These complexes tend to adopt a layered biphasic structure with 21 
crystallinity depending on the length of the surfactant alkyl chain and a periodical spacing 22 
sensitive to temperature. Negatively charged polysaccharides, and in particular polyuronic 23 
acids, have been demonstrated to behave in a way not far from that described for anionic 24 
polypeptides. Thus coupling of alginic, pectinic and hyaluronic acids with 25 
alkyltrimethylammonium surfactants has been recently reported to render stable ionic 26 
complexes arranged in layers showing order at the nanometric scale (Tolentino, Alla, Martínez 27 
de Ilarduya, & Muñoz-Guerra, 2011, 2013).   28 
 In this paper we wish to report on ionic complexes made from hyaluronic acid and an 29 
arginine-based compound, namely ethyl N-lauroyl L-arginate hydrochloride (LAE), which are 30 
able to display antimicrobial properties. Due to the increasing resistance of bacteria to 31 
antibiotics, bactericide polymers start to be considered today as an attractive antiseptic 32 
alternative (Engler et al., 2012). In such systems, the polymer acts as a matrix for holding and 33 
controlling the release of the antimicrobial agent so that the possible toxicity associated to the 34 
biocide is largely repressed and the period of activity increased when compared to the neat 35 
biocide. During the last decade the attention given to polymeric materials with antimicrobial 36 
activity has been very noticeable (Santos et al., 2016) and some hyaluronic acid-based 37 
materials incorporating antimicrobial agents may be found in the recent literature. HyA-silver 38 
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nanoparticles and HyA coupled with polyhexanide (Baier et al, 2013; Kemp et al., 2009), and 39 
nisin polypeptide (Lequeux, Ducasse, Jouenne, & Thebault, 2014) are representative examples 40 
of such materials. To our knowledge, no study addressed to examine the ionic LAE·HyA 41 
complexes including their antimicrobial activity has been described so far. 42 
Hyaluronic acid (HyA) is a high molecular weight mucopolysaccharide composed of 43 
repeating disaccharide units of -1,3-N-acetyl D-glucosamine and -1,4-D-glucuronic acid with a 44 
great capacity to retain moisture and to form hydrogels with excellent viscoelastic properties. 45 
Furthermore HyA is high biocompatible, non-immunogenic and susceptible to biodegradation by 46 
human hyaluronidases. HyA is always present in the human body in small amounts, and it is 47 
widely used in medicine, cosmetic and veterinary surgery (Necas, Bartosikova, Brauner, & 48 
Kolar, 2008; Stern, Kogan, Jedrzejas, & Šoltés, 2007). The polysaccharide may be chemically 49 
modified to render biomaterials with properties suitable for tissue engineering (Allison & Grande-50 
Allen, 2006; Burdick & Prestwich, 2011; Schanté, Zuber, Herlin, & Vandamme, 2011). Rooster 51 
combs were the traditional source of HyA but today it is mainly produced by microbial 52 
fermentation which has boosted its applications and raised its commercial value (Liu, Liu, Li, Du, 53 
& Chen, 2011). On the other hand, LAE is a synthetic surfactant consisting of an ethyl esterified 54 
arginine head with a lauroyl tail attached to the -amino group. LAE is widely recognized as a 55 
highly powerful preservative agent for a large variety of food-borne bacteria (Becerril, Manso, 56 
Nerin, & Gómez-Lus, 2013; Otero et al., 2014) a property that is due to its ability for altering the 57 
microorganisms metabolism without producing cellular disruptions (Rodriguez, Seguer, 58 
Rocabayera, & Manresa, 2004). LAE has been assessed to be nontoxic and it has been 59 
classified by FDA (Food and Drug Administration) as GRAS (Generally Recognized as Safe) at 60 
concentrations up to 200 ppm.  According to their biological properties, ionic coupling of LAE 61 
with HyA is envisaged as a very convenient approach to build antimicrobial films with potential 62 
use in food preservation and design of medical antiseptic devices.  63 
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The working hypothesis for this research is that LAE·HyA complexes will be readily 64 
formed with prefixed compositions, and that they will show strong activity against pathogens 65 
because LAE will be released under control to the wet environment by water-mediated 66 
dissociation of the ionic pair. LAE and HyA are largely expected to combine ionically because 67 
both compounds have been reported to form stable ionic complexes when they enter in contact 68 
with diverse counter-ions. Thus LAE is known to interact positively with the anionic 69 
polysaccharides present in the food (Asker, Weiss, & McClements, 2009; Loeffler et al., 2014), 70 
and complexes of HyA with a diversity of organocationic compounds have been also described 71 
(Battistini et al., 2017; Bračič, Hansson, Pérez, Zemljič, & Kogej, 2015; Chytil, Trojan, & 72 
Kovalenko, 2016; Tolentino, Alla, Martínez de Ilarduya, & Muñoz-Guerra, 2013). Complexes of 73 
LAE with poly(-glutamic acid) (LAE·PGGA) with antibacterial properties have been recently 74 
described by us (Gamarra-Montes, Missagia, Morató, & Muñoz-Guerra, 2017). 75 
   In this paper cationic LAE is coupled with the polyanionic hyaluronic acid to obtain the 76 
ionic complexes abbreviated as LAE·HyA with LAE to HyA ratios of either 1:1 or 1:2. These 77 
complexes are extensively characterized by different techniques (FT-IR, NMR, TGA, DSC, XRD 78 
and POM) and paying detailed attention to the nanostructure. Then the release rate of LAE from 79 
complexes is estimated under different conditions and the antimicrobial properties of the films 80 
are evaluated in vitro experiments against both Gram-positive (L. monocytogenes and S. 81 
aureus) and Gram-negative bacteria (S. enterica and E.coli).  82 
 
2. Experimental  83 
2.1. Materials 84 
The sample of sodium salt of hyaluronic acid (Na·HyA) with a weight-average of 50,000 85 
Da was purchased from Enze Chemicals. The 1H NMR spectrum ascertaining the identity of this 86 
sample is provided in the Supplementary Material file (SM) associated to this article (Figure S1). 87 
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The sample of Ethyl N-lauroyl L-arginate hydrochloride (LAE) used in this work was a kind gift 88 
from Vedeqsa Grupo LAMIRSA (Terrassa, Barcelona).  89 
2.2. Measurements 90 
FTIR spectra within the 4000-600 nm range were recorded from powder samples on a 91 
Perkin Elmer Frontier equipment provided with an ATR accessory. 1H NMR spectra were 92 
recorded on a Bruker AMX-300 NMR instrument operating at 300.1 MHz. Samples were 93 
dissolved in deuterated methanol and TMS was used as internal reference. Thermogravimetric 94 
analysis (TGA) was performed over the 30 to 600 ºC interval at a heating rate of 10 ºC·min-1 95 
under an inert atmosphere on a Mettler-Toledo TGA/DSC 1 Star System thermobalance. 96 
Sample weights of 10-15 mg were used for this analysis. Differential scanning calorimetry 97 
(DSC) was carried out on a Perkin-Elmer DSC 8000 instrument calibrated with indium and zinc. 98 
Heating-cooling cycles at a rate of 10 ºC·min-1 under a nitrogen atmosphere within the -30 to 99 
200 ºC temperature range were applied for the analysis using  sample weights of  2-5 mg. X-ray 100 
diffraction studies were performed using X-ray synchrotron radiation at the BL11 beamline 101 
(NCD, Non-Crystalline Diffraction) of ALBA synchrotron in Cerdanyola del Vallès, Barcelona. 102 
Simultaneous SAXS and WAXS were taken in real time from powder samples subjected to 103 
heating-cooling cycles at a rate of 10 ºC·min-1. The radiation energy employed corresponded to 104 
0.1 nm wavelength, and spectra were calibrated with silver behenate (AgBh) and Cr2O3 for small 105 
and wide angle diffraction, respectively. Optical microscopy was carried out on an Olympus 106 
BX51 polarizing optical microscope (POM) equipped with a digital camera and a Linkam THMS-107 
600 hot stage provided with nitrogen gas circulating system. Samples for POM observation 108 
were prepared by evaporation at room temperature of a 3 % (w/w) solution of the complex in 109 




2.3. Complexes formation and film preparation 111 
 The methodology used by (Ponomarenko, Waddon, Tirrell, & MacKnight, et al.,1996) for 112 
the preparation of ionic complexes from poly(-amino acids) and ionic surfactants was applied 113 
in this work. This methodology with some slight modifications has been used by us for the 114 
synthesis of complexes made from either PGGA or polyuronic acids and quaternary 115 
tetraalkylammonium salts bearing long linear alkyl chains containing from 12 to 22 carbon 116 
atoms (Pérez-Camero et al., 2004; Tolentino, Alla, Martínez de Ilarduya, & Muñoz-Guerra, 117 
2011a, 2013) and also for the preparation of LAE·PGGA complexes (Gamarra-Montes, 118 
Missagia, Morató, & Muñoz-Guerra, 2017). The procedure applied here is essentially as follows: 119 
A solution of LAE hydrochloride in water was slowly poured into a solution of NaHyA in water 120 
under mild stirring at a temperature around 35 ºC. The complex precipitated as a white powder 121 
after several hours of standing. The precipitate was recovered by centrifugation and repeatedly 122 
washed with water and finally dried under vacuum for at least 48 h. Complexes were prepared 123 
from mixtures containing both 1:1 and 1:2 molar ratios of LAE to HyA, and they are abbreviated 124 
as LAE·HyA-1 and LAE·HyA-0.5, respectively. 125 
Consistent films made of LAE·HyA complexes were prepared by casting a solution of the 126 
complex in methanol on 3x3 cm2 Petri plates and leaving it to dry at room temperature for 24 h. 127 
Films were cut in 1x1 cm2 squares and further dried under vacuum for 24 h. Film thickness were 128 
estimated to be 105 ± 5 μm as measured by using a Mitutoyo micrometer (Osaka, Japan).  129 
2.4. Complex dissociation and bactericide activity 130 
For evaluation of the dissociation of LAE·HyA complexes upon incubation in aqueous 131 
medium, LAE·HyA complex films were suspended in 2 mL of buffer and the suspension placed 132 
into cellulose membrane tubes (2000 Da cut-off) and dialysis performed against 10 mL of the 133 
same buffer for a week. Assays were carried out at pH= 7.4 and 5.5 at 25 ºC, and the amount of 134 
LAE released to the environment was determined by measuring the absorbance of the dialysate 135 
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at 220 nm at prefixed incubation times. Aqueous buffers used for incubation were prepared from 136 
mixtures of disodium hydrogen phosphate and potassium hydrogen phosphate according to the 137 
European Pharmacopea 5.0.  138 
The antimicrobial activity of LAE·HyA complexes over time was tested in vivo against both 139 
Gram-negative and Gram-positive bacteria in liquid culture media. Cultures of S. enterica CECT 140 
4594, E. coli NCTC 9001, L. monocytogenes ATCC 19115 and S. aureus ATCC 6538 were 141 
obtained from the National Collection of Type Cultures (NCTC, Public Health England, UK), the 142 
Spanish Type Culture Collection (CECT, Valencia, Spain) and the American Type Culture 143 
Collection (ATCC, USA), respectively. The organisms were stored at -20°C in tryptic soy broth 144 
(TSB; Merck, Darmstadt, Germany) containing 50% (v/v) glycerol until used. To activate them, a 145 
loopful of each bacterium was spread to give single colonies on tryptic soy agar (TSA; Difco 146 
Laboratories) petri dishes, and incubated at 37 °C for 24 h. Representative colonies were then 147 
picked out and suspended into 10 mL tubes of TSB pH 7.0, and incubated at 37 °C for 24 hours 148 
to obtain early stationary phase cells (optical density of 0.9 at 600 nm). The cultures were then 149 
inoculated (100 µL) into fresh TSB, and incubated at 37 °C for 18 h to reach the exponential 150 
phase (optical density of 0.2 at 600 nm). At this stage the bacteria cultures were diluted to 151 
obtain a concentration of 105 CFU·mL-1. 100 µL of these bacterial suspensions were then 152 
transferred to sterile tubes containing an approximate 1 cm2-film piece of HyA (negative control), 153 
LAE·HyA-1,  or  LAE·HyA-0.5  in 10 mL of fresh TSB. The tubes were placed in a thermostated 154 
oven at 37 °C and 100 µL aliquots were removed from the suspension at selected periods of 155 
time (2, 8 and 24 hours), diluted with peptone water (1% v/v), and plated in petri dishes with 15 156 
mL of TSA culture medium. A bacterial suspension prepared in the same way but without film 157 
added was used as blank.  Quantification of colonies was made in triplicates and data are 158 
represented as logarithm of colony forming units (Log(CFU)). Formulae used for logarithm 159 
reduction value (LRV) and percent reduction calculation were the following (Durán, Marcato, De 160 
Souza, Alves, & Esposito, 2007), 161 
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Log reduction value = log10 (A/B)            Percentage reduction = [(A-B)/A]·100 162 
where A and B are the number of viable bacteria in the negative control and after treatment with 163 
either LAE·HyA-1 or LAE·HyA-0.5. 164 
 
3. Results and discussion 165 
3.1. Synthesis of complexes 166 
 The preparation of LAE·HyA complexes was performed according to Scheme 1. Mixing at 167 
35 ºC of the two aqueous solutions containing LAE and Na·HyA, respectively, rendered the 168 
complex as a white precipitated that could easily recovered by centrifugation. Two LAE·HyA 169 
molar ratios, i.e 1:1 and 1:2, were used at mixing with the purpose of obtaining complexes with 170 
equal or half molar amount of LAE respect to HyA. The 1H NMR analysis revealed that the 171 
actual compositions of the complexes were very close to those used for feeding with a slight 172 








Scheme 1. Formation of LAE·HyA complexes by coupling reaction of LAE with hyaluronic acid. LAE to 181 
HyA ratios of 1:1 and 1:2 were used. 182 
 
 
3.2. Chemical characterization  183 
  The FTIR spectra recorded from the LAE·HyA complexes are shown in Figure 1 together 184 

















































data of the two components (Gilli et al., 1994; Gamarra, Missagia, Morató, Muñoz-Guerra, 186 
2017). The spectra of the complexes include the bands characteristic of the two counterparts 187 
with relative intensities according to composition. In fact, the digital region of these spectra over 188 
the 1800-650 cm-1 may be made to correspond to the overlapping of those observed for HyA 189 
and LAE with their contributions being proportional to their contents in the complexes. In 190 
particular the bands characteristic of LAE appearing at 1526 and 1176 cm-1 are detected in the 191 
complexes with intensity increasing with the LAE:HyA ratio. Also the bands at 2917 and 2840 192 
cm-1 due to the stretching of C-H bonds, which are shared by the two components but with much 193 
higher intensity in LAE, increase in parallel to the content of this compound in the complex. On 194 
the other hand, the strong band displayed by HyA at c.a. 1030 cm-1 and arising from C-O-C 195 
stretching keeps the same features in the spectra of the complexes. Finally just to notice that 196 
the broad absorption displayed by HyA in the 3500-3200 cm-1 region, which is attributed to 197 
hydroxyl groups, is fully retained in the complexes impeding the visualization of the weak NH 198 
stretching peaks expected to arise from the LAE counterpart. 199 
 200 
 201 
Table 1. Synthesis, thermal properties and structural data. 
Compound  Synthesis results  Thermal properties  X-ray diffraction data (nm)  
















































HyA  - - - -  200 228 35  -  n.d. n.d. n.d.  n.d. n.d. n.d.  
LAE·HyA-0.5  0.02 35 70 0.4 :1.0  217 228/328 19  -  3.8 3.8 3.7  0.45 0.45 0.45  
LAE·HyA-1  0.01 35 80 0.9 :1.0  228 259/328 11  -  3.9 3.9 3.8  0.45 0.45 0.45  
LAE  - - - -  245 275/311 10  62  3.0 - -  m
g 
- -  
a Concentration of the two solutions mixed to form the complex. 
b
 Mixing temperature selected according to the LAE solubility in water.  
c  Molar ratio of LAE to HyA in the complex estimated by 1H NMR. 
d ºTd and 
maxTd: onset (5% weight loss) and maximum rate decomposition temperatures; W: remaining weight after heating at 600 ºC. 
e Tm is the melting temperature recorded by scanning calorimetry. 
f
 Small angle (SAXS) and wide angle (WAXS) X-rays scattering  recorded at 10 ºC, 120 ºC and 10 ºC (after cooling)  as indicated. 
 n.d.: not determined. 
















Figure 1. Comparison of FTIR spectra of LAE, HyA and their complexes with indication of most 215 
characteristic bands.  216 
 217 
  218 
 The 1H NMR spectrum recorded from LAE-HyA-1 in methanol solution is reproduced in 219 
Figure 2 with all signals consistently assigned to the chemical structure of the complex. The 220 
spectra of LAE, HyA, and the LAE-HyA-0.5 complex may be inspected in the SM file (Figures 221 
S1 and S2). In the complexes’ spectra, signals due to of the HyA counterpart are according to 222 
that reported for the complexes made from HyA and alkyltrimethylammonium surfactants 223 
(Tolentino,  Alla, Martínez de Ilarduya & Muñoz-Guerra,  2013), and those arising from the 224 
surfactant counterpart coincide almost exactly with those observed in the spectrum of pristine 225 
LAE.  In general signals appear well resolved although those arising from the inner methylenes 226 
of the dodecyl group of LAE appear overlapped (k,l), and those due to the protons of the 227 
pyranose rings are grouped in two undifferentiated broad signals (2-5 and 2’-6’).  228 
 229 
 230 












































H NMR spectrum of LAE·HyA-1 recorded in MeOD. *Signals arising from the solvent. 231 
 232 
 Signals arising from the anomeric proton of the glucuronic unit of HyA and the -233 
methylene protons of the lauroyl moiety of LAE (signals 1 and j) were used to determine the 234 
composition of the complexes. The relative area quantification of these signals revealed that the 235 
complexes have compositions very close to those used for their synthesis (Table 1), with 236 
deviations within the range that could be expected according to results obtained for other ionic 237 
complexes of HyA previously studied by us (Tolentino,  Alla, Martínez de Ilarduya & Muñoz-238 
Guerra,  2013; Gamarra, Missagia, Morató, Muñoz-Guerra, 2017).  239 
 240 
3.2.  Thermal properties and structure 241 
 Firstly the thermal stability of the complexes was evaluated by TGA. The traces registered 242 
for both LAE-HyA-1 and LAE-HyA-0.5 over the 20-600 ºC were compared with those of HyA 243 
and LAE in Figure 3a, and their respective derivative curves are represented in Figure 3b. It 244 
should be noted that the trace of HyA shows a weight loss of about 5% at temperatures around 245 
100 ºC, which is interpreted as due to the release of the remaining adsorbed water that could 246 
not be removed by the drying treatment applied to the sample. Nevertheless, all compounds 247 
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started to decompose above 200 ºC at an onset temperature that increases with the content in 248 
LAE. Furthermore, the maximum decomposition rate in LAE took place around 50 ºC higher 249 
than for HyA. These differences are reflected in the complexes which show maxTd  of 230 ºC and 250 
260 ºC for LAE-HyA-0.5 and LAE-HyA-1, respectively. It can be stated on the basis of these 251 
results that the LAE·HyA complexes could be comfortably handled in the case that usual 252 










Figure 3. TGA traces of HyA, LAE and the LAE·HyA complexes recorded under an inert atmosphere (a), 262 
and their respective derivative curves (b). 263 
 
 The DSC analysis (Figure 4a) revealed that only LAE shows melting transition whereas 264 
almost plain traces were registered for HyA and their complexes (the slight endotherm 265 
appreciated on the trace of HyA in the 80-120 ºC interval is very likely due to water 266 
evaporation). The crystalline nature of LAE was clearly evidenced in the spherulitic texture that 267 
is seen in films of this compound prepared by casting when they are observed by POM (Figure 268 
4b left). Accordingly, it can be concluded that the crystallinity of LAE is lost when this compound 269 
is attached to HyA. However, POM of the LAE·HyA-1 film showed a fan-like texture typical of a 270 
smectic mesophase (Figure 4b right) indicating that complexes are ordered in a crystal liquid 271 





















































































Figure 4. a) First heating DSC traces recorded from LAE and its ionic complexes. b) POM micrographs 274 
taken from LAE (left) and LAE·HyA-1 (right) thin films at 25 ºC.  275 
 
 
  The XRD scattering recorded in the WAXS region for LAE and the complexes (Figure 5a) 276 
was in full agreement with DSC results. The trace recorded for LAE contains a large number of 277 
well-defined peaks, as it should be expected for a crystalline organic compound, whereas a 278 
broad hill centered around 0.45 nm is the only alteration appearing on the traces of the 279 
complexes. In the SAXS region (Figure 5b), spectra of both LAE and complexes show an 280 
apparent sharp peak corresponding to a repeat distance of 3.0 nm for the former and around 281 
3.9-3.8 nm for the latter. These results confirm the occurrence of an ordered arrangement at the 282 
nanometric level in the complexes in spite that they are not crystallized.  283 
 With the purpose of assessing the influence of temperature on these structures, samples 284 
of LAE and LAE·HyA-1 were subjected to a heating-cooling cycle over the 10-120 ºC range at a 285 
rate of 10 ºC·min-1, and the changes taking place in the X-ray scattering were registered over 286 














the whole temperature range at real time (Figure 6). Both SAXS and WAXS signals observed 287 
for LAE fully disappeared when temperature reached 60-65 ºC, which is clear evidence that the 288 












Figure 5. XRD profiles recorded at 10 ºC from LAE and their complexes LAE·HyA in the WAXS (a) and 290 
SAXS regions (b). 291 
 
not show any discrete scattering (see Figure S4 in the SM file) indicating that the initial structure 
present in LAE was not recovered. The behavior observed for LAE·HyA-1 was noticeably 
different. The 3.9 nm peak remained unchanged along the whole heating treatment bringing into 
evidence the stability of the mesophase up to temperatures close to 200 ºC. This is consistent 
with the observations made by POM in which the birefringence displayed by the films of 
LAE·HyA-1 did not vanished when subjected to heating at similar temperatures. Similar results 
were obtained in the XRD/POM analysis of LAE·HyA-0.5 complex (Figures S5  in SM). It seems 
reasonable to assume therefore that higher temperatures are needed to destroy the liquid 
crystal phase adopted by these complexes, an assumption that unfortunately cannot be tested 
since their thermal decomposition starts to be noticeable at 215-230 ºC. As much expected, the 
















WAXS profiles arising from the average interatomic distances present in the disordered phase 





Figure 6. Evolution of the SAXS and WAXS profiles of LAE (a and a’) and LAE·HyA-1 (b and b’) at 292 
heating from 10 to 120 °C.  293 
 
 
3.3. LAE release and antimicrobial properties 294 
According to the hypothesis formulated for this work, the biocide activity expected for the 295 
LAE·HyA complexes should arise from the free LAE that is released to the environment as a 296 
consequence of the dissociation undergone by the ionic pair upon incubation in an aqueous 297 
medium. To evaluate the capacity of these complexes to deliver LAE under conditions 298 
commonly found in food environments, the amount of LAE that is released from both LAE·HyA-299 
1 and LAE·HyA-0.5 and accumulated in the incubation medium at pH 7.4 and 5.5 was 300 
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measured by UV absorption at 220 nm, and results are compared in Figure 7. In all cases, the 301 
dissociation equilibrium was reached within an incubation period of 4 to 8 h. The concentration 302 
of LAE attained at that time was much higher at pH 7.4 than at pH 5.5 and, as largely expected, 303 
the accumulated amount of free LAE noticeably increased with the LAE:HyA ratio in the 304 
complex. An additional experiment carried out at pH 7.4 but at a temperature of 4 ºC revealed 305 
that cooling delayed the release of LAE in an extent similar to that observed for decreasing the 306 












Figure 7. Dissociation of LAE·HyA complexes upon incubation in aqueous medium at pH= 7.4 and 5.5 at 308 
25 ºC.  309 
 
 The bactericide activity of films made of LAE·HyA-1 and LAE·HyA-0.5 complexes at pH 310 
7.4 and 37 ºC was evaluated by in vitro assays applying the liquid medium method and using as 311 
substrates two pairs of bacteria representatives of the Gram-positive (L. monocytogenes and S. 312 
aureus) and Gram-negative (S. enterica and E. coli) groups. A fast appraisal of the bactericidal 313 
effect could be made by visual inspection of the tubes which revealed disappearance of the 314 







LAE·HyA-1   pH= 7.4 pH= 5.5










initial turbidity for all the cases after 24 h of incubation (Figure S7, SM file). Quantitative results 315 
of these preliminary assays expressed as Log(CFU) (colony forming units), Log(RV) (reduction 316 
value) and PR (percentage of reduction) are compared in the bar graphs of Figure 8 for the four 317 
bacteria, and numerical values of these results are collected in the Table S1 of the SM file. As it 318 
can be inferred from the graphs, the antimicrobial activity of both, LAE·HyA-1 and LAE·HyA-0.5, 319 
is noticeable from the earlier incubation stages so they inhibited the growth of all bacteria just 320 
after 2 h of contact. This activity was found especially important against Gram-negative bacteria 321 
so that Log(RV) values of 6.6 and 4.7 for S. enterica, and 3.6 and 3.9 for E. coli was measured 322 
for LAE·HyA-1 and LAE·HyA-0.5, respectively. This result is remarkable since Gram-negative 323 
bacteria are usually less sensible to cationic surfactants than Gram-positive bacteria due to the 324 
outer lipopolysaccharide coat that surrounds the cell wall (Vaara, 1992).  325 
The antimicrobial activity of the complexes against Gram-positive bacteria was found to 326 
be lower with Log(RV) of 0.2 and 0.4 observed for L. monocytogenes and 1.1 and 0.4 for S. 327 
aureus for LAE·HyA-1 and LAE·HyA-0.5, respectively, after 2 h of incubation. The higher 328 
antimicrobial efficacy observed for the complex containing more LAE is quite reasonable and 329 
according to observations reported on antimicrobial films based on LAE loaded chitosan 330 
(Higueras, López-Carballo, Hernández-Muñoz, Gavara, & Rollini, 2013). However, it was 331 
interesting to see that the antimicrobial activity of the LAE·HyA-0.5 complex against S. aureus 332 
became higher than that of LAE·HyA-1 when long incubation times (8 and 24 h) have elapsed. 333 
This behaviour may be convincingly explained by taking into account the observations reported 334 
by Baier et al (Baier et al., 2013) on the biocide activity of HyA-based nanocapsules containing 335 
the antimicrobial agent polyhexanide. They found that S. aureus was particularly sensitive to the 336 
biocide agent incorporated in such systems because its release was favored by the 337 
biodegradation of HyA, a process that happened due to the action of the hyaluronidases 338 
















Figure 8. Antimicrobial activity of LAE·HyA-1 and LAE·HyA-0.5 films over time against Gram-positive and 340 
Gram-negative bacteria. 341 
 
   
 
4. Conclusions 342 
The well recognized biocide guanidinium-based compound LAE was coupled with 343 
hyaluronic acid to render ionic complexes with two compositions, i.e LAE:HyA = 1 and 0.5. 344 
These complexes were non-soluble in water and stable to heat up to temperatures above 200 345 
ºC. Although the genuine crystallinity of LAE was lost when it was incorporated in the complex, 346 
a smectic liquid crystal arrangement was adopted by both LAE·HyA-1 and LAE·HyA-0.5. The 347 
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nanostructure of the complexes is characterized by a periodicity of about 3.8-3.9 nm 348 
corresponding to the repeating distance of an alternating array of HyA and LAE layers in which 349 
the undecyl tail of the lauroyl group of LAE is in the disordered state. These complexes 350 
dissociated upon incubation in an aqueous medium in a range of hours providing free LAE at 351 
equilibrium concentrations depending on pH and complex composition. Films prepared from 352 
these complexes displayed significant biocide activity against both Gram-positive and Gram-353 
negative bacteria with the highest efficiency being shown by LAE·HyA-1 against S. enterica.  354 
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